Kopran Ltd.

•

kopran.comBSE: 524280NSE: KOPRAN

Market Cap₹ 1,120 Cr.

Current Price

High / Low₹ 240 / 107

Stock P/E33.3

Book Value₹ 94

Price to Book1.17

Dividend Yield1.29 %

ROCE9.2 %

ROE6.9 %

Face Value₹ 10

Add ratio to table

ABOUT

KEY POINTS

Revenue Breakup Mar 2026 • Tablet / Capsules / Liquids: 98.7% • Others: 0.9% • Pharmaceuticals: 0.4%

AI Sector View

AI GENERATED

Healthcare

Buy

This stance relies on proxies and positioning because no direct pharma-export or healthcare operating series exists in the dataset. The depreciated currency at 95.23 (Sep/26) can support export earnings, inflation at 4.45% (Jul/26) is manageable for a defensive sector, and consumer spending remains large at INR 44743 billion (Jun/26). Strong FPI inflow of INR 10620 crore over 3 months to 2026-08-31 from INR -11381 crore in the prior 3 months adds a real sector-specific tailwind, but confidence stays capped because the fundamental drivers are indirect proxies.

Confidence

50%

View full sector analysis →

PROS

Latest quarter profit grew 91.0% YoY, showing strong momentum
Strong cash generation - operating cash flow backs reported profits (CFO/PAT 0.96x)
Company has been maintaining a healthy dividend payout of 47.7%
Working capital cycle has improved - days down from 142 to 111
Company comfortably covers its interest (10.6x coverage)
Company has a consistent dividend-paying track record

CONS

Receivables are growing faster than sales - a possible quality concern
Company has a low return on equity of 7.3% over last 3 years
Company has a low return on capital employed of 9.7%
Company has delivered a poor profit growth of 5.3% over past five years
Company has delivered a poor sales growth of 6.5% over past five years

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

HealthcareHealthcarePharmaceuticals & Drugs

Part ofNIFTY 50 NIFTY 500 NIFTY LARGEMIDCAP 250 NIFTY 100 NIFTY 200

S.No.	Name
1.	SUNPHARMA	1904.00	37.77	456833.38	0.84	2901.23	26.53	15299.88	10.98	19.11	28.81
2.	DIVISLAB	9245.00	83.91	245425.70	0.32	902.00	65.50	3080.00	27.80	21.51	40.75
3.	TORNTPHARM	4924.70	85.89	187319.76	0.77	566.00	3.28	4921.00	57.32	19.27	33.81
4.	ZYDUSLIFE	1135.00	25.09	113216.68	0.09	990.20	-34.90	8017.00	23.97	21.39	24.54
5.	CIPLA	1389.00	33.29	112211.54	0.94	785.55	-39.18	7119.28	4.13	16.00	16.73
6.	LAURUSLABS	1872.15	92.52	101154.55	0.11	3620.70	2139.42	20263.10	1191.00	18.20	31.50
7.	LUPIN	2135.00	17.66	97626.26	0.84	1416.98	16.01	8276.89	34.28	28.86	29.59
8.	MANKIND	2345.00	47.42	96859.07	0.04	574.09	29.12	4030.59	12.89	13.24	26.30
9.	DRREDDY	1155.00	29.92	96405.53	0.69	435.60	-69.10	8099.80	-5.21	13.75	10.63
10.	AUROPHARMA	1627.00	25.22	93613.98	0.25	1032.03	25.22	9150.35	17.44	12.76	20.54
11.	GLENMARK	2458.80	38.60	69393.40	0.10	482.83	927.88	4018.48	31.35	20.35	20.03
12.	KOPRAN	232.05	44.85	1120.47	1.29	6.70	-10.04	153.99	13.88	6.65	10.26

Detailed Comparison with:

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	66	99	82	91	50	74	72	76	51	42	94	118	63
	65	90	70	75	44	64	61	64	46	46	76	91	57
Operating Profit	1	9	12	15	5	10	11	12	5	-3	18	27	6
OPM %	1.25%	8.82%	14.65%	16.93%	10.64%	13.18%	15.85%	16.18%	9.89%	-7.57%	18.82%	22.53%	9.35%
	1	6	1	8	2	1	1	2	2	0	0	1	3
Interest	1	1	1	2	1	1	1	1	1	1	1	1	1
Depreciation	1	1	1	1	1	1	1	1	1	1	1	1	1
Profit before Tax	0	13	11	21	6	9	10	12	5	-5	16	25	9
Tax %	30.43%	15.26%	23.75%	25.50%	23.05%	24.46%	24.62%	26.56%	23.64%	18.07%	22.14%	25.25%	23.47%
Net Profit	0	11	9	15	4	7	7	9	4	-4	12	19	7
	0.03	2.21	1.77	3.18	0.88	1.37	1.54	1.78	0.73	-0.83	2.51	3.88	1.39

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
	182	154	197	179	223	205	273	337	271	306	317
	164	146	174	156	193	189	245	301	232	258	270
Operating Profit	17	7	23	23	30	15	28	37	39	48	47
OPM %	9.56%	4.72%	11.54%	12.93%	13.53%	7.46%	10.22%	10.93%	14.26%	15.57%	14.80%
	9	10	3	2	10	8	16	17	6	2	5
Interest	10	7	5	6	4	3	3	5	4	4	4
Depreciation	3	3	3	3	4	4	4	5	5	5	5
Profit before Tax	13	7	17	16	33	16	37	45	36	40	45
Tax %	36.31%	32.38%	25.27%	28.68%	28.23%	27.34%	15.34%	22.19%	24.97%	24.74%	24.60%
Net Profit	9	5	13	11	23	12	31	35	27	30	34
EPS	0.00	0.00	0.00	0.00	5.43	2.65	6.48	7.18	5.56	6.30	—
Dividend Payout %	0.00%	0.00%	0.00%	0.00%	27.64%	123.15%	46.28%	41.76%	53.94%	47.65%	—

COMPOUNDED SALES GROWTH

10 Years:: 5%
5 Years:: 7%
3 Years:: 4%

COMPOUNDED PROFIT GROWTH

10 Years:: 10%
5 Years:: 5%
3 Years:: -1%

STOCK PRICE CAGR

10 Years:: 17%
5 Years:: 1%
3 Years:: -2%
1 Year:: 38%

RETURN ON EQUITY

10 Years:: 6%
5 Years:: 7%
3 Years:: 7%
Last Year:: 7%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	43	43	43	43	43	48	48	48	48	48
	158	162	175	186	204	331	347	368	382	398
	50	45	41	36	16	37	28	23	45	46
Trade Payables	36	29	32	32	40	30	62	52	46	76
	19	17	24	28	22	19	20	21	25	38
Total Liabilities	306	297	316	326	324	464	506	511	546	606
	39	38	42	43	47	46	47	52	61	82
Capital Work in Progress	3	5	1	1	0	0	0	0	2	0
	157	157	158	158	159	259	260	261	263	265
	25	30	25	41	28	42	48	49	56	66
	0	0	0	0	0	0	0	88	92	133
Cash & Bank	2	2	1	1	3	3	3	7	21	2
	80	65	89	82	87	114	148	53	51	59
Total Assets	306	297	316	326	324	464	506	511	546	606

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	5	16	16	14	54	-34	23	35	23	30
Cash from Investing	-9	-2	-4	1	-9	-100	10	-6	-15	-30
Cash from Financing	5	-11	-7	-11	-40	138	-26	-24	6	-19
	-0	-0	-0	0	0	-0	1	5	14	-19

Ratios

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
PER SHARE
EPS (₹)	1.97	1.09	3.00	2.59	5.43	2.44	6.48	7.18	5.56	6.30
Book Value (₹)	46.46	47.57	50.51	53.10	57.07	78.56	82.05	86.25	89.02	92.46
Dividend per Share (₹)	0.00	0.00	0.00	0.00	1.50	3.00	3.00	3.00	3.00	3.00
Cash EPS (₹)	2.74	1.83	3.72	3.40	6.38	3.33	7.40	8.14	6.60	7.33
PROFITABILITY
Operating Margin %	14.58%	10.94%	13.17%	14.03%	18.22%	11.46%	16.11%	10.92%	14.26%	15.57%
Net Margin %	4.68%	3.06%	6.59%	6.26%	10.53%	5.74%	11.44%	10.26%	9.91%	9.95%
ROE %	4.37%	2.31%	6.12%	5.01%	9.85%	3.75%	8.07%	8.54%	6.35%	6.94%
ROCE %	9.50%	5.28%	8.67%	7.98%	13.57%	5.64%	9.44%	11.36%	8.63%	9.19%
	2.91%	1.56%	4.24%	3.50%	7.22%	2.98%	6.44%	6.81%	5.08%	5.28%
EFFICIENCY
Debtor Days	58	69	60	89	75	97	95	93	121	134
Inventory Days	53	65	51	68	56	62	60	53	71	73
Payable Days	137	154	109	134	106	119	107	102	136	154
	-25	-19	2	22	26	39	48	44	55	53
FINANCIAL HEALTH
Debt to Equity (x)	0.28x	0.25x	0.23x	0.20x	0.06x	0.10x	0.07x	0.05x	0.11x	0.10x
Interest Coverage (x)	2.36x	2.05x	4.18x	3.64x	9.59x	6.47x	14.82x	10.89x	10.50x	10.62x
	1.31x	1.31x	1.44x	1.36x	1.62x	1.98x	1.89x	2.22x	2.02x	1.63x
GROWTH
Revenue Growth %	-3.08%	-15.34%	27.94%	-8.83%	24.29%	-8.22%	33.53%	23.57%	-19.69%	12.78%
Operating Profit Growth %	2.74%	-36.49%	54.13%	-2.90%	61.38%	-42.29%	87.71%	21.90%	-16.92%	11.25%
Net Profit Growth %	-25.65%	-44.65%	175.58%	-13.50%	109.20%	-49.97%	166.11%	10.83%	-22.46%	13.19%
	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	10.83%	-22.58%	13.20%
VALUATION
P/E (x)	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	35.97x	31.48x	17.14x
P/B (x)	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	3.00x	1.97x	1.17x
Dividend Yield %	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	1.16%	1.71%	2.78%
	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	23.51x	19.52x	11.40x

Shareholding Pattern

Numbers in percentages

	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	44.49	44.49	44.46	44.42	44.42	44.42	44.42	44.42	44.42
	0.68	1.31	0.86	1.11	0.76	0.60	0.36	0.57	0.51
	0.14	0.22	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Government	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
	54.70	53.97	54.68	54.45	54.82	54.98	55.22	55.00	55.06

Documents

Corporate disclosures, annual reports, credit ratings, and concall transcripts

2026-09-01

Spurt in Volume

2026-09-01 - Significant increase in volume has been observed in Kopran Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Kopran Limited has submitted their response.

2026-08-31

Spurt in Volume

2026-08-31 - Significant increase in volume has been observed in Kopran Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, has written to the company. The response from the company is awaited.

2026-08-18

Shareholders meeting

2026-08-18 - Proceedings of AGM, Voting result and Scrutiniser's report.

2026-08-10

Copy of Newspaper Publication

2026-08-10 - Kopran Limited has informed the Exchange about Copy of Newspaper Publication

2026-08-07

Investor Presentation

2026-08-07 - Kopran Limited has informed the Exchange about Investor Presentation

2026-08-07

Outcome of Board Meeting

2026-08-07 - Kopran Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.

2026-07-20

Copy of Newspaper Publication

2026-07-20 - Kopran Limited has informed the Exchange about Copy of Newspaper Publication

2026-07-16

Record Date

2026-07-16 - Kopran Limited has informed the Exchange that Record date for the purpose of Dividend is 11-Aug-2026.

2026-07-09

Certificate under SEBI (Depositories and Participants) Regulations, 2018

2026-07-09 - Kopran Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

News

Recent coverage and analyst commentary for KOPRAN

Loading news…

🤖

AI Stock Analyst

Kopran Ltd.

🔒

Sign in to Chat with AI

✨ Sign In to Chat

Free 5nance Account

Name

SUNPHARMA

1904.00

37.77

456833.38

0.84

2901.23

26.53

15299.88

10.98

19.11

28.81

DIVISLAB

9245.00

83.91

245425.70

0.32

902.00

65.50

3080.00

27.80

21.51

40.75

TORNTPHARM

4924.70

85.89

187319.76

0.77

566.00

3.28

4921.00

57.32

19.27

33.81

ZYDUSLIFE

1135.00

25.09

113216.68

0.09

990.20

-34.90

8017.00

23.97

21.39

24.54

CIPLA

1389.00

33.29

112211.54

0.94

785.55

-39.18

7119.28

4.13

16.00

16.73

LAURUSLABS

1872.15

92.52

101154.55

0.11

3620.70

2139.42

20263.10

1191.00

18.20

31.50

LUPIN

2135.00

17.66

97626.26

0.84

1416.98

16.01

8276.89

34.28

28.86

29.59

MANKIND

2345.00

47.42

96859.07

0.04

574.09

29.12

4030.59

12.89

13.24

26.30

DRREDDY

1155.00

29.92

96405.53

0.69

435.60

-69.10

8099.80

-5.21

13.75

10.63

AUROPHARMA

1627.00

25.22

93613.98

0.25

1032.03

25.22

9150.35

17.44

12.76

20.54

GLENMARK

2458.80

38.60

69393.40

0.10

482.83

927.88

4018.48

31.35

20.35

20.03

KOPRAN

232.05

44.85

1120.47

1.29

6.70

-10.04

153.99

13.88

6.65

10.26

Jun 2023

Sep 2023

Dec 2023

Mar 2024

Jun 2024

Sep 2024

Dec 2024

Mar 2025

Jun 2025

Sep 2025

Dec 2025

Mar 2026

Jun 2026

118

Operating Profit

-3

OPM %

1.25%

8.82%

14.65%

16.93%

10.64%

13.18%

15.85%

16.18%

9.89%

-7.57%

18.82%

22.53%

9.35%

Interest

Depreciation

Profit before Tax

-5

Tax %

30.43%

15.26%

23.75%

25.50%

23.05%

24.46%

24.62%

26.56%

23.64%

18.07%

22.14%

25.25%

23.47%

Net Profit

-4

0.03

2.21

1.77

3.18

0.88

1.37

1.54

1.78

0.73

-0.83

2.51

3.88

1.39

Mar 2017

Mar 2018

Mar 2019

Mar 2020

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

Mar 2026

TTM

182

154

197

179

223

205

273

337

271

306

317

164

146

174

156

193

189

245

301

232

258

270

Operating Profit

OPM %

9.56%

4.72%

11.54%

12.93%

13.53%

7.46%

10.22%

10.93%

14.26%

15.57%

14.80%

Interest

Depreciation

Profit before Tax

Tax %

36.31%

32.38%

25.27%

28.68%

28.23%

27.34%

15.34%

22.19%

24.97%

24.74%

24.60%

Net Profit

EPS

0.00

5.43

2.65

6.48

7.18

5.56

6.30

—

Dividend Payout %

0.00%

27.64%

123.15%

46.28%

41.76%

53.94%

47.65%

—

Mar 2017

Mar 2018

Mar 2019

Mar 2020

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

Mar 2026

Equity Capital

158

162

175

186

204

331

347

368

382

398

Trade Payables

Total Liabilities

306

297

316

326

324

464

506

511

546

606

Capital Work in Progress

157

158

159

259

260

261

263

265

133

Cash & Bank

114

148

Total Assets

306

297

316

326

324

464

506

511

546

606

Mar 2017

Mar 2018

Mar 2019

Mar 2020

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

Mar 2026

-34

Cash from Investing

-9

-2

-4

-9

-100

-6

-15

-30

Cash from Financing

-11

-7

-11

-40

138

-26

-24

-19

-0

-19

Mar 2017

Mar 2018

Mar 2019

Mar 2020

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

Mar 2026

PER SHARE

EPS (₹)

1.97

1.09

3.00

2.59

5.43

2.44

6.48

7.18

5.56

6.30

Book Value (₹)

46.46

47.57

50.51

53.10

57.07

78.56

82.05

86.25

89.02

92.46

Dividend per Share (₹)

0.00

1.50

3.00

Cash EPS (₹)

2.74

1.83

3.72

3.40

6.38

3.33

7.40

8.14

6.60

7.33

PROFITABILITY

Operating Margin %

14.58%

10.94%

13.17%

14.03%

18.22%

11.46%

16.11%

10.92%

14.26%

15.57%

Net Margin %

4.68%

3.06%

6.59%

6.26%

10.53%

5.74%

11.44%

10.26%

9.91%

9.95%

ROE %

4.37%

2.31%

6.12%

5.01%

9.85%

3.75%

8.07%

8.54%

6.35%

6.94%

ROCE %

9.50%

5.28%

8.67%

7.98%

13.57%

5.64%

9.44%

11.36%

8.63%

9.19%

2.91%

1.56%

4.24%

3.50%

7.22%

2.98%

6.44%

6.81%

5.08%

5.28%

EFFICIENCY

Debtor Days

121

134

Inventory Days

Payable Days

137

154

109

134

106

119

107

102

136

154

-25

-19

FINANCIAL HEALTH

Debt to Equity (x)

0.28x

0.25x

0.23x

0.20x

0.06x

0.10x

0.07x

0.05x

0.11x

0.10x

Interest Coverage (x)

2.36x

2.05x

4.18x

3.64x

9.59x

6.47x

14.82x

10.89x

10.50x

10.62x

1.31x

1.44x

1.36x

1.62x

1.98x

1.89x

2.22x

2.02x

1.63x

GROWTH

Revenue Growth %

-3.08%

-15.34%

27.94%

-8.83%

24.29%

-8.22%

33.53%

23.57%

-19.69%

12.78%

Operating Profit Growth %

2.74%

-36.49%

54.13%

-2.90%

61.38%

-42.29%

87.71%

21.90%

-16.92%

11.25%

Net Profit Growth %

-25.65%

-44.65%

175.58%

-13.50%

109.20%

-49.97%

166.11%

10.83%

-22.46%

13.19%

0.00%

10.83%

-22.58%

13.20%

VALUATION

P/E (x)

0.00x

35.97x

31.48x

17.14x

P/B (x)

0.00x

3.00x

1.97x

1.17x

Dividend Yield %

0.00%

1.16%

1.71%

2.78%

0.00x

23.51x

19.52x

11.40x

Jun 2024

Sep 2024

Dec 2024

Mar 2025

Jun 2025

Sep 2025

Dec 2025

Mar 2026

Jun 2026

44.49

44.46

44.42

0.68

1.31

0.86

1.11

0.76

0.60

0.36

0.57

0.51

0.14

0.22

0.00

Government

0.00

54.70

53.97

54.68

54.45

54.82

54.98

55.22

55.00

55.06

Kopran Ltd.

AI Sector View

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Corporate actions

Cash Flows

Ratios

Shareholding Pattern

Documents

News

Sign in to Chat with AI

Kopran Ltd.

AI Sector View

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Corporate actions

Cash Flows

Ratios

Shareholding Pattern

Documents

News

Sign in to Chat with AI